Information Provided By:
Fly News Breaks for February 15, 2017
CYNO, HOLX
Feb 15, 2017 | 07:42 EDT
Canaccord analyst Mark Massaro said he did not expect Hologic (HOLX) to make such a big acquisition when it bought Cynosure (CYNO), but he likes the deal and expects it to add to top-line growth. With its recent deals, Hologic swapped out a declining business for a double digit grower, added Massaro, who reiterated his Buy rating and $48 price target on Hologic shares.
News For HOLX;CYNO From the Last 2 Days
There are no results for your query HOLX;CYNO